Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Aug 2014
At a glance
- Drugs Sarpogrelate (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Therapeutic Use
- Acronyms SONATA
- Sponsors Yuhan
- 31 Aug 2018 Biomarkers information updated
- 05 Aug 2014 Last checked against ClinicalTrials.gov record.
- 09 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.